Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic – Novo Nordisk (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a…
UnitedHealth Heads Into Q4 Earnings As Elevated Medical Costs Loom — Is Stability In Sight? – UnitedHealth Group (NYSE:UNH)
With health insurer UnitedHealth Group Inc. (NYSE:UNH) set to report its fourth-quarter results on Tuesday, investors remain focused…